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Background: The action of probiotics has been studied in vitro in cells isolated from both mice and humans,
particularly enterocytes (IECs), dendritic cells (DCs) and co-cultures of peripheral DCs and IECs. Peripheral DCs and
murine DCs differ from human gut DCs, and to date there are no data on the action of any probiotic on co-cultured
human IECs and human intestinal DCs. To address this issue, a novel transwell model was used. Human IECs (Caco-2 cells)
grown in the upper chamber of transwell filters were co-cultured with intestinal-like human DCs grown in the basolateral
compartment of the transwells. The system was apically exposed for 4 h to live probiotic L. paracasei CNCM
I-4034 obtained from the faeces of breastfed infants or to its cell-free culture supernatant (CFS) and challenged
with Salmonella typhi. The secretion of pro- and anti-inflammatory cytokines in the basolateral compartment
was determined by immunoassay, and the DC expression pattern of 20 TLR signaling pathway genes was
analysed by PCR array.
Results: The presence of the live probiotic alone significantly increased IL-1β, IL-6, IL-8, TGF-β2, RANTES and IP-10 levels
and decreased IL-12p40, IL-10, TGF- β1 and MIP-1α levels. This release was correlated with a significant increase in the
expression of almost all TLR signaling genes. By contrast, incubation of the co-culture with CFS increased IL-1β, IL-6,
TGF-β2 and IP-10 production only when Salmonella was present. This induction was correlated with an overall decrease
in the expression of all TLR genes except TLR9, which was strongly up-regulated.
Conclusions: The data presented here clearly indicate that L. paracasei CNCM I-4034 significantly increases the
release of pro-inflammatory cytokines, enhances TLR signaling pathway activation and stimulates rather than
suppresses the innate immune system. Furthermore, our findings provide evidence that the effects of probiotics
in the presence of IECs and DCs differ from the effects of probiotics on cultures of each cell type alone, as
reported by us earlier. Thus, co-culture systems such as the one described here are needed to characterise the
effects of probiotics in vitro, highlighting the potential utility of such co-cultures as a model system.
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Intestinal homeostasis is regulated by tight crosstalk be-
tween intestinal epithelial cells (IECs) and immune cells,
especially dendritic cells (DCs) [1]. Signaling via innate
pattern-recognition receptors (PRRs) such as Toll-like
receptors (TLRs), NOD-like receptors (NLRs) and C-
type lectin receptors (CLRs) [2] directly influences the
chemokine and cytokine response of DCs, as well as the
crosstalk between the epithelium and immune cells in
the lamina propria [3]. This signaling occurs largely
through activation of the transcription nuclear factor
kappa B (NF-κB) or mitogen-activated protein kinase
(MAPK) pathways [4]. Furthermore, several studies have
demonstrated that the typical phenotype of mucosal
DCs can be obtained after co-culture with polarised
epithelial cells, creating a “tolerogenic” environment [5,6].
Probiotics are live microorganisms that have beneficial
effects on the host. Although their mechanism of action
is poorly understood [2], they are considered to be
promising alternatives to antibiotics for the control and
prevention of intestinal infections [7,8]. Lactobacillus
paracasei CNCM I-4034 is a novel probiotic strain that
was obtained from the faeces of breastfed infants and
selected based on its probiotic properties, including
adhesion to intestinal mucus, sensitivity to antibiotics
and resistance to gastrointestinal juices, biliary salts,
NaCl and low pH [9]. Previously, we reported that L.
paracasei culture supernatant inhibits the growth of
enterotoxigenic and enteropathogenic bacteria such as
E. coli, Salmonella and Shigella [10].
In vitro studies of host immune responses have fo-
cused on probiotics and enterocytes or DCs. However,
single cultures do not reflect the interactions occurring
in the intestinal mucosa [11]. Thus, it is important to
develop in vitro systems that include both DCs and
IECs, both of which are crucial for intestinal homeosta-
sis. Using a co-culture model including Caco-2 cells
(IECs) and PBMCs, Haller et al. reported differential
IEC activation by Escherichia coli and Lactobacillus
strains [12]. However, PBMCs and murine DCs are quite
different from human DCs [13]. Recently, using human
intestinal-like DCs as a model, we reported the ability of
L. paracasei CNCM I-4034 and its cell-free culture
supernatant (CFS) to activate these immune cells [14].
Interestingly, these human DCs are Langerhans-like cells
that extend dendritic processes and sample antigens
similarly to the lamina propria DCs in the gut that sample
luminal antigens [15]. We demonstrated previously that
exposure to Salmonella enterica serovar typhi (S. typhi)
led to reduced production of pro-inflammatory cytokines
and chemokines in the presence of the probiotic and its
supernatant. Both enhanced innate immune responses
through the activation of TLR signaling pathway [14].
Our results coincide with those of another studyindicating that live probiotic bacteria affect the intes-
tinal immune response, whereas secreted components
exert anti-inflammatory effects in the gastrointestinal
tract [16]. Continue with this line, in the present work
we investigated whether L. paracasei CNCM I-4034
or its CFS modulates the release of cytokines by
intestinal-like DCs through a physical barrier of Caco-
2 cells and measured the effects that occur when the
system is challenged with S. typhi. In addition, the
expression pattern of selected TLR cascade signaling
genes under these conditions was studied. The novel
transwell model described here may better mimic the
in vivo situation in which beneficial commensal probiotics
interact with host immune cells via enterocytes.
Methods
Ethic statement
The ethical Committee of Granada’s University ap-
proved this study. This study was conducted according
to the guidelines laid down in the Declaration of
Helsinki and the protocol using human DCs generated
from umbilical cord blood CD34+ progenitor cells was
approved by the Ethical Committee of the University
of Granada.
Design of the study
A model was developed based on an in vitro transwell
co-culture of IECs and human intestinal-like DCs.
Caco-2 cells were cultured in the upper part of the
transwell inserts, with human intestinal-like DCs in
the lower chamber. L. paracasei CNCM I-4034 and
S. typhi CECT 725, as well as CFS from L. paracasei,
were added apically either alone or in combination
(Figure 1). Negative control co-cultures were not ex-
posed to any bacteria or CFS. As a positive control
of TLR signaling pathway activation E. coli lipopoly-
saccharide (LPS) stimulation was used.
Bacterial strains and culture conditions
L. paracasei CNCM I-4034, which was selected for its
immunomodulatory capacity, was isolated from the fae-
ces of breast-fed newborns [9]. The probiotic strain was
grown in De Man-Rogosa-Sharpe (MRS) broth medium
(Oxoid, Basingstoke, United Kingdom) under anaerobic
conditions at 37°C. The bacterial cultures were grown
overnight until they reached the stationary phase.
Salmonella typhi CECT 725 was provided by the
Spanish Type Culture Collection (CECT; Burjassot, Spain).
Salmonella was cultured for 8 h at 37°C in tryptone soy
broth (Panreac Química, Barcelona, Spain) and then sub-
cultured 1:500 in RPMI 1640 medium (Sigma-Aldrich)
containing 10% foetal bovine serum (FBS; Gibco Invitro-
gen, Paisley, United Kingdom) at 37°C overnight.
Probiotic


















Figure 1 Design of the study. A illustrates the in vitro transwell model. A monolayer of intestinal epithelial cells (IECs) is formed on a membrane
separating two compartments. Human intestinal-like dendritic cells (DCs) are seeded on the lower chamber. B is a schematic diagram of the cellular
constituents of the intestinal mucosa. CFS: cell-free supernatant of probiotic; V: voltmeter.
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CNCM I-4034
The CFS was prepared as described by Bermudez-Brito
et al. [14]. Briefly, the bacteria were grown in MRS
broth for 24 h. The L. paracasei culture was centri-
fuged at 12,000 × g for 10 min, neutralised to pH 7.0
with 1 N NaOH and concentrated tenfold by lyophil-
isation. The CFS was filter-sterilised using 0.22-μm
pore size filters (Minisart hydrophilic syringe filter; Sar-
torius Stedim Biotech GmbH, Goettingen, Germany) and
stored at −20°C until use. The supernatant was added at
7% v/v.Preparation of epithelial cell monolayers
Caco-2 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) (Sigma-Aldrich) supplemented
with 10% inactivated FBS, 1% glutamine, penicillin G
(0.1 U/ml), and streptomycin (0.1 mg/ml). The cells
were cultured at 37°C in an atmosphere of 5% CO2 and
95% air. Caco-2 cells were seeded in the upper chamber
of a transwell filter (3 μm pore size, 6.5 mm diameter;
Corning, NY) and incubated for 15–21 days. The cells
were grown to confluence (until the trans-epithelial
resistance (TER) reached 300 Ωcm2).Dendritic cells
Human intestinal-like DCs generated from umbilical
cord blood CD34+ progenitor cells (haematopoietic
stem cells) were supplied by MatTek Corporation
(Ashland, MA) and maintained according to the sup-
plier’s instructions [15].Co-culture of Caco-2 cells and intestinal-like DCs and
incubation with L. paracasei or its cell-free supernatant
and S. typhi
Transwell inserts containing adherent monolayers of
Caco-2 cells were positioned upside down in a 6-well
plate, and 5 × 104 DCs were placed on the membrane.
The DCs were allowed to adhere to the filters at 37°C.
After 4 h, the transwell inserts were turned right side up
and placed in 24-well plates containing 3 × 105 DCs/well
in the lower chamber. L. paracasei CNCM I-4034
(107 CFU/ ml), its CFS or S. typhi CECT 725 (106 CFU/
ml) were added from the apical surface (top chamber),
and the cells were incubated for 4 h. Combinations of
the probiotic or its CFS with S. typhi were prepared
similarly. For the incubations, fresh cytokine and
antibiotic-containing medium (DC-MM) was replaced
with RPMI-1640 medium. After incubation, the bac-
teria or CFS were washed out of the wells, and the
medium was replaced with DC-MM. After 20 h, the
culture supernatants were collected from the lower
chamber for cytokine analysis, and the DCs in that
compartment were collected for RNA extraction.
LPS at 20 ng/ml (Sigma-Aldrich) was used as a posi-
tive control. Negative control cultures contained un-
stimulated co-cultured DCs and Caco-2 cells.
Cytokine and chemokine quantification in culture
supernatants
IL-1β, IL-6, IL-8, IL-10, IL-12 (p40), IL-12 (p70), TNF-α,
IFN-γ, MCP-1/CCL2, MIP-1α/CCL3, RANTES/CCL5,
MDC/CCL22, IP-10/CXCL10 and TGF-β were mea-
sured by immunoassay with a MILLIplex™ kit (Linco
Research Inc, Missouri, USA) using the Luminex 200
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Three independent experiments were performed.
Extraction of RNA from DCs and evaluation of the
expression of selected genes of the TLR signaling
pathway
Briefly, DCs collected from the lower chamber were lysed,
and total RNA was extracted using the RNAqueous Kit
(Ambion, Paisley, United Kingdom) and Turbo DNase
treatment (Ambion) according to the manufacturers’
recommendations. The quality of the RNA was verified on
a Model 2100 Bioanalyzer (Agilent, Santa Clara, USA), and
the RNA concentration was determined using a Rediplate
96 Ribogreen RNA Quantitation Kit (Gibco Invitrogen).
Three samples were taken per treatment.
Real time RT-PCR analysis was carried out using a
Human TLR Signaling Pathway PCR Array (SABios-
ciences Corporation, Frederick, Maryland, USA), which
includes primer pairs specific for 20 selected genes re-
lated to TLR-mediated signaling pathways, as previously
described by Bermudez-Brito et al. [14]. The expression
level of each gene was analysed with RT2 Profiler PCR
Array Data Analysis software (version 3.4; SABios-
ciences). The change in expression of each gene was
reported as the fold change in expression (Fc). The
results reflect logarithmic fold increase relative to the
control samples.
Finally, IECs collected from the transwell membrane
were lysed, and total RNA was extracted using the same
method as described above. Real time RT-PCR analysis
was carried out using a Human TLR Signaling Pathway
PCR Array. The results are provided as [Additional files
1, 2, 3 and 4].
Statistical analysis
All data are expressed as the mean ± standard error of
the mean (SEM) of three independent experiments. A
two-sided Mann–Whitney U-test was used to determine
changes in cytokine release and Fc gene differences
between treatments. Statistical calculations were per-
formed using NCSS 2007 software (Kaysville, UT). Dif-
ferences between the treated cells and the controls were
considered statistically significant when the P values
were less than 0.05 (*).
Results
Live L. paracasei CNCM I −4034 is a potent inducer of
cytokine production
We first studied the effects of the probiotic strain and
its CFS on cytokine and chemokine production in co-
cultures of human DCs and IECs. As shown in Figures 2,
3 and 4, we found that live L. paracasei CNCM I-4034
was a potent inducer of the pro-inflammatory cytokinesIL-1β and IL-6 and the chemokine IL-8. In addition, we
found that L. paracasei CNCM I-4034 increased the
production of TGF-β2, RANTES/CCL5 and IP-10/
CXCL10. In contrast, it decreased IL-12p40 (Figure 2),
IL-10, TGF- β1 (Figure 3) and MIP-1α (Figure 4) levels
but had no effect on IL-12p70 (Figure 2) levels or on the
levels of any of the other chemokines tested (Figure 4).
As expected, LPS stimulation (the positive control)
induced strong production of IL-6 and IL-8 (Figure 2).
TNF-α was also induced; however, the difference never
reached statistical significance (Figure 3). LPS did not
induce chemokine release (Figure 4).
When we analysed the cytokines produced by co-
cultures exposed to L. paracasei CFS, we found that the
cells were not very responsive to the CFS (Figures 2, 3
and 4). CFS-treated co-cultures exhibited a cytokine and
chemokine profile similar to that of negative controls
(non-exposed co-cultures) but showed less induction of
TGF-β1 and β2 (Figure 3) and IP-10 (Figure 4).
Live probiotic L. paracasei notably increases the release
of cytokines and chemokines in the presence of
Salmonella
With respect to cytokine production, incubation of the
co-culture with Salmonella alone did not increase the
secretion of pro-inflammatory cytokines or chemokines
(Figures 2, 3 and 4); only IL-6, IL-10, TGF-β1 and MIP-
1α levels were slightly modified.
As shown in Figures 2, 3 and 4, co-treatment with
live L. paracasei CNCM I-4034 and Salmonella in-
duced the release of a number of cytokines such as
IL-6 and TNF-α and of chemokines such as MIP-1α/
CCL3 and RANTES/CCL5; however, it induced less
TGF-β2. Furthermore, this treatment increased IL-10
production. No effects on MCP-1/CCL2, MDC/CCL22,
TGF-β1 or IL12p70 levels were observed.
In contrast, incubation with L. paracasei CFS and S.
typhi resulted in increased release of the pro-inflammatory
cytokines IL-1β, IL-6 and IL-8 (Figure 2), TGF-β2
(Figure 3), RANTES/CCL5 and IP-10/CXCL10 pro-
duction (Figure 4) and decreased TGF-β1 production
(Figure 3).
L. paracasei and its supernatant induce distinct
strain-specific expression profiles of TLR signaling
pathway molecules in human DCs
Remarkably, most of the TLR signaling pathway genes
tested in DCs were up-regulated upon incubation of
the co-culture with L. paracasei CNCM I-4034 alone
(Figures 5, 6, 7 and 8). The probiotic strain augmented
TLR1, TLR4, TLR5 and TLR9 gene expression (Figures 5
and 6). In addition, the live probiotic induced up-
regulation of TOLLIP (Figure 6), CASP8 (Figure 7) and
IL-10 (Figure 8).
Figure 2 Effects of L. paracasei CNCM I-4034 and its cell-free culture supernatant on the secretion of pro-inflammatory cytokines by
intestinal-like human dendritic cells through an epithelial layer. The production of IL-1β (Panel A), IL-6 (Panel B), IL-8 (Panel C), IL-12 (p40)
(Panel D) and IL-12 (p70) (Panel E) was measured. DCs and Caco-2 cells were incubated for 4 h with the live probiotic L. paracasei or its supernatant,
Salmonella, or both and further incubated for 20 h in medium containing antibiotics. The culture supernatants were collected from the lower chamber,
and the cytokine levels in the supernatants were determined by immunoassay. The data shown are the mean and SEM of the values obtained in three
different experiments. *, p<0.05 compared with controls; #, p<0.05 compared with S.typhi.
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Figure 3 Measurement of anti-inflammatory cytokines and TNF-α in DCs through an epithelial layer after exposure to L. paracasei,
Salmonella or a combination of the two. The production of IL-10 (Panel A), TNF-α (Panel B), TGF-β1 (Panel C) and TGF-β2 (Panel D) was
measured. DCs and Caco-2 cells were incubated for 4 h with the live probiotic L. paracasei or its supernatant, Salmonella or both and further incubated
for 20 h in medium containing antibiotics. The culture supernatants were collected from the lower chamber, and the cytokine levels were determined
by immunoassay. The data shown are the mean and SEM of the values obtained in three different experiments. *, p<0.05 compared with controls; #,
p<0.05 compared with S.typhi; N.D. indicates not detected.
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Figure 4 Measurement of chemokines in DCs through an epithelial layer after exposure to L. paracasei, Salmonella or a combination of
the two. The production of MCP-1/CCL2 (Panel A), MIP-1α/CCL3 (Panel B), RANTES/CCL5 (Panel C), MDC/CCL22 (Panel D) and IP-10/CXCL10
(Panel E) was measured. DCs and Caco-2 cells were incubated for 4 h with the live probiotic L. paracasei or its supernatant, Salmonella or both
and further incubated for 20 h in medium containing antibiotics. The culture supernatants were collected, and the cytokine levels were determined by
immunoassay. The data shown are the mean and SEM of the values obtained in three different experiments. *, p<0.05 compared with controls; #,
p<0.05 compared with S.typhi; N.D. indicates not detected.
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Figure 5 Expression of TLR genes in DCs in the presence of L. paracasei, Salmonella or a combination of the two. Comparison of the
expression of TLR1 (Panel A), TLR2 (Panel B), TLR3 (Panel C), TLR4 (Panel D) and TLR5 (Panel E) in dendritic cells (DCs) taken from the lower
chamber of a transwell co-culture model in the presence of the live probiotic L. paracasei or its supernatant, Salmonella or both. The fold change
(Fc) represents the ratio of the expression in the treated DCs to that of expression in the control cells. *, p<0.05 compared with controls; #,
p<0.05 compared with S.typhi; N.D. indicates not detected.
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Figure 6 Expression of TLR signaling pathway components in DCs treated with L. paracasei, Salmonella or a combination of the two.
Comparison of the expression of TLR9 (Panel A), MYD88 (Panel B), IRAK-1 (Panel C), IRAK-4 (Panel D) and TOLLIP (Panel E) in dendritic cells
(DCs) taken from the lower chamber of a transwell co-culture model in the presence of the live probiotic L. paracasei or its supernatant, Salmonella or
both. The fold change (Fc) represents the ratio of the expression in the treated DCs to that of expression in the control cells. *, p<0.05 compared with
controls; #, p<0.05 compared with S.typhi; N.D. indicates not detected.
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Figure 7 Expression of TLR signaling pathway components in DCs treated with L. paracasei, Salmonella or a combination of the two.
Comparison of the expression of CASP8 (Panel A), TAK-1 (Panel B), JNK (Panel C), IRF-3 (Panel D) and MAPK14 (Panel E) in dendritic cells (DCs)
taken from the lower chamber of a transwell co-culture model in the presence of the live probiotic L. paracasei or its supernatant, Salmonella or
both. The fold change (Fc) represents the ratio of the expression in the treated DCs to that of expression in the control cells. *, p<0.05 compared
with controls; #, p<0.05 compared with S.typhi; N.D. indicates not detected.
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Figure 8 Expression of TLR signaling pathway components in DCs treated with L. paracasei, Salmonella or a combination of the two.
Comparison of the expression of NFKBIA (Panel A), NFKB-1 (Panel B), TBK-1 (Panel C), IL-10 (Panel D) and TNF-α (Panel E) in dendritic cells (DCs)
taken from the lower chamber of a transwell co-culture model in the presence of the live probiotic L. paracasei or its supernatant, Salmonella or
both. The fold change (Fc) represents the ratio of the expression in the treated DCs to that of expression in the control cells. *, p<0.05 compared
with controls; #, p<0.05 compared with S.typhi; N.D. indicates not detected.
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DC TLR-selected genes except TLR9, which was up-
regulated, and IRAK4, the expression of which was
slightly increased (Figures 5 and 6).
When DCs and Caco-2 cells were co-cultured with live
probiotic L. paracasei and Salmonella, strong and sus-
tained transcription of most of the genes associated with
TLR signaling pathways was observed in the human
DCs (Figures 5, 6, 7 and 8). TLR1, TLR2, TLR4 and
TLR9 gene expression was increased. Interestingly, in
the presence of the enteropathogen, exposure to the
live probiotic up-regulated MYD88 (Figure 6), CASP8
(Figure 7), NFKB1 and TBK1 (Figure 8) as well as
other genes. Remarkably, the presence of the probiotic
strain and Salmonella induced strong up-regulation of
TAK1 (Figure 7).
Interestingly, simultaneous incubation of the co-
culture with L. paracasei CFS and Salmonella exerted a
similar effect on TLR gene expression to that of CFS
alone except for JNK expression, which was strongly up-
regulated (Figure 7). Both CFS alone and CFS and
Salmonella treatments decreased NFKBIA gene expres-
sion (Figure 8).
Analysis of TLR signaling pathway genes of Caco-2
cells collected from the transwell membrane is provided
as Additional files 1, 2, 3 and 4.
Discussion
To the best of our knowledge, this is the first study in
which the immune response elicited by probiotics has
been analysed using an in vitro bilayer system that
includes human IECs growing on transwell membranes
and human intestinal-like DCs developed from CD34+
progenitor cells isolated from umbilical cord blood.
Moreover, in an attempt to mimic the in vivo conditions
under which DCs are able to open tight junctions
between adjacent epithelial cells and take up bacteria
directly from the intestinal lumen [17], the transwell
inserts were inverted and the human intestinal-like DCs
were allowed to adhere to the IECs for 4 h [18,19]. This
culture system will facilitate functional studies, including
studies of host-microbe interactions.
Live L. paracasei CNCM I-4034 alone was a potent
inducer of IL-1β, IL-6 and IL-8. Moreover, in the presence
of Salmonella, L. paracasei induced the production of
almost all the cytokines analysed including IL-6, IL-8 and
TNF-α, which are regulated by NF-κB [19], conversely to
the results reported by our group in single cultures, either
in Caco-2 cells [20] or in DCs [14], in which the probiotic
L. paracasei down-regulated a broad array of pro-
inflammatory cytokines in the presence of Salmonella.
Altogether, the results suggest that L. paracasei enhances
innate immunity via NF-κB activation rather than sup-
pression. Furthermore, the stimulation of other innateimmunity pathways, i.e., ERK mediated IL-10 production
and TGF-β production mediated by P38 MAPK, ERK, and
JNK, could also be involved [21,22]. This activation of
innate immunity may help strengthen intestinal defence
and epithelial barrier function.
TGF-β is considered a key immunoregulatory factor in
promoting immunoglobulin A (IgA) production [23] and
maintaining immune tolerance [24,25]. In this context,
live L. paracasei stimulated TGF-β2 release. Further-
more, CFS is a potent inducer of TGF-β2 in response to
S. typhi. Immunomodulatory effects of TGF-β2 have
been reported in conditions such as atopy and systemic
inflammatory response syndrome [26,27]. In addition,
IL-6 was notably secreted upon stimulation of cells with
live L. paracasei alone or with L. paracasei and its CFS
in the presence of Salmonella. Probiotic strains have
been described as potent inducers of IL-6 [28] and
enhancers of IgA responses [29]. Uematsu et al. [30]
proposed that commensal bacteria induce IgA produc-
tion through a mechanism mediated by TLR5, an inter-
pretation that is consistent with our results. Altogether,
these results suggest that L.paracasei could lead to the
generation of IgA and reinforce epithelial barrier func-
tion because secreted IgA limits bacterial association
with the intestinal epithelial surface and restricts the
penetration of pathogens across the gut epithelium [31],
precluding a systemic immune response [32]. Interest-
ingly, this argument is strengthened by our recent ob-
servation that Bifidobacterium breve CNCM I-4035
administration increases secretory IgA content after
30-day intervention in healthy volunteers [33].
In contrast, IECs and DCs were poorly responsive to S.
typhi, contrary to the results reported by Zoumpopoulou
et al. [1] and Vossenkämper et al. [19]. In addition, S.
typhi was unable to induce the release of chemokines
such as RANTES and induced low levels of MIP-1α.
However, it is important to note that Salmonella did
induce changes in the expression of TLR signaling path-
way genes in human DCs. These changes in gene expres-
sion may be due to crossing of the monolayer by
bacterial compounds or to direct contact between the
pathogen and DCs that crept between the epithelial cells
and contacted the pathogen directly from the luminal
side. Taken together, our results suggest that Salmonella
cells were not able to penetrate the epithelial layer and
interact directly with the DCs. In addition, TLR genes ex-
pression in IECs was decreased in response of Salmonella
stimuli [see Additional file 1]. Furthermore, Salmonella
just induced the expression of MyD88, Casp8, TAK1 and
NFKBIA in IECs [see Additional files 1, 2, 3 and 4]. Thus,
the low cytokine profile observed in the co-cultured DCs
and IECs could be due to the action of IECs and bacter-
ial compounds that crossed the monolayer. Conse-
quently, IECs not only form a physical barrier to
Bermudez-Brito et al. BMC Microbiology  (2015) 15:79 Page 13 of 15bacteria but also regulate DC cytokine production,
possibly through epithelial cell-derived factors [34,35],
and could contribute to prevention of an exaggerated
inflammation and thereby to the maintenance of im-
mune homeostasis in the gut [36].
Interestingly, the culture supernatant exhibited activity
when Salmonella was present, in agreement with our
previous findings [14]. These data indicate that soluble
bacterial product(s) released by L. paracasei CNCM
I-4034 were able to cross the epithelial monolayer
and activate the DCs in the lower chamber. Moreover,
IECs and DCs are able to recognise probiotic secreted
factor(s) without inducing inflammatory reactions [35].
This culture supernatant modulated the ability of the
DCs to produce inflammatory cytokines in response to
pathogens.
Previous results obtained by our group suggest that
probiotics modulate the cytokine profile in immune cells
through TLRs stimulation [14]. We therefore analysed
the expression of TLRs in DCs taken from the lower
chamber of our co-culture system. The first of these
experiments showed that few genes were up-regulated
by the supernatant in DCs. Exposure to CFS led to an
overall decrease in expression of all the TLR genes
except TLR9, which was strongly up-regulated. This up-
regulation was also found in our previous study in
immune cells. Conversely, the expression of this TLR
was decreased in IECs. Moreover, the expression of
TLR1, TLR3 and TLR4 was up-regulated upon CFS
stimulation [see Additional files 1 and 2]. Because CFS
by itself did not induce cytokine production, TLR9 may
have a key role in the context of probiotic-host inter-
actions, and the results suggest that the immunomod-
ulatory effects of L. paracasei product(s) may involve
mechanisms that overlap with those associated with
CpG [14,2]. Moreover, down-regulation of TLRs genes
may block the production of pro-inflammatory cyto-
kines. Interestingly, JNK gene expression in DCs was
notably increased with this treatment, whereas in
IECs was down-regulated [see Additional file 3]. JNK
phosphorylation leads to the activation of transcrip-
tion factors such as NF-κB, which directs the produc-
tion of pro-inflammatory cytokines [37], consistent
with our results. Overall, it appears that in the pres-
ence of infectious agents, the supernatant of L. para-
casei promotes cytokine production and thereby
enables the cells to combat pathogens.
In the presence of Salmonella and the live probiotic,
TLR2 and TLR9 were slightly up-regulated in DCs,
whereas TLR1, TLR2, TLR3 and TLR4 were increased in
IECs. Like the results of several previous studies, our
results suggest that exposure to live L. paracasei
increases the expression of TLR2 and TLR9, activating
innate immunity in immune cells [38-40]. Furthermore,TLR2 stimulation appears to enhance the epithelial bar-
rier, and it has been shown that activation of this TLR
plays an essential role in resistance to bacterial invasion.
Several studies have described increased expression of
TLR9 after the administration of probiotics such as L.
johnsonii [41]. In this line, and according with our
results, it has been shown a protective role for TLR1
during bacterial infection via its signaling in the intes-
tinal epithelium [42]. TLR4 was also up-regulated in our
experiments in DCs and IECs. TLR4 can recognise LPS
present in the walls of Gram-negative bacteria [43] and
plays a key role in defence against Salmonella [30]. In
the presence of Salmonella, TNF-α gene expression is
up-regulated, a finding that correlates with the observed
cytokine profile. Altogether, these results suggest that
when pathogens are present, L. paracasei promotes the
local stimulation of innate immune responses in the gut
through the activation of NF-κB, thus preventing
systemic inflammation. Follow-up studies are ongoing
to evaluate whether this probiotic strain can exert a
protective effect in vivo in a murine model.
Conclusions
This study demonstrates that the effects of probiotics
should be studied on complex of cells because cultures
of single cell types do not exhibit the effects of the
exposure to a probiotic strain. DCs react differently to
probiotics and pathogens in the presence and absence of
IECs. Co-culture models such as the one presented here
will facilitate the study of host-microbe interactions.
Moreover, this system also provides a feasible platform
for the development of novel probiotics or other agents
for further animal studies and clinical trials.
Additional files
Additional file 1: Figure S1. Expression of TLR genes in IECs in the
presence of L. paracasei, Salmonella or a combination of the two.
Comparison of the expression of TLR1 (Panel A), TLR2 (Panel B), TLR3
(Panel C), TLR4 (Panel D) and TLR5 (Panel E) in Caco-2 cells (IECs) taken
from the transwell membrane of a co-culture model in the presence of
the live probiotic L. paracasei or its supernatant, Salmonella or both. The
fold change (Fc) represents the ratio of the expression in the treated IECs
to that of expression in the control cells.
Additional file 2: Figure S2. Expression of TLR signaling pathway
components in IECs treated with L. paracasei, Salmonella or a combination
of the two. Comparison of the expression of TLR9 (Panel A), MYD88
(Panel B), IRAK-1 (Panel C), IRAK-4 (Panel D) and TOLLIP (Panel E) in Caco
2-cells (IECs) taken from the transwell membrane of a transwell co-culture
model in the presence of the live probiotic L. paracasei or its supernatant,
Salmonella or both. The fold change (Fc) represents the ratio of the
expression in the treated IECs to that of expression in the control cells.
Additional file 3: Figure S3. Expression of TLR signaling pathway
components in IECs treated with L. paracasei, Salmonella or a
combination of the two. Comparison of the expression of CASP8
(Panel A), TAK-1 (Panel B), JNK (Panel C), IRF-3 (Panel D) and MAPK14
(Panel E) in Caco-2 cells (IECs) taken from the transwell membrane of a
transwell co-culture model in the presence of the live probiotic
Bermudez-Brito et al. BMC Microbiology  (2015) 15:79 Page 14 of 15L. paracasei or its supernatant, Salmonella or both. The fold change (Fc)
represents the ratio of the expression in the treated IECs to that of
expression in the control cells.
Additional file 4: Figure S4. Expression of TLR signaling pathway
components in IECs treated with L. paracasei, Salmonella or a
combination of the two. Comparison of the expression of NFKBIA (Panel
A), NFKB-1 (Panel B), TBK-1 (Panel C), IL-10 (Panel D) and TNF-α (Panel E) in
Caco-2 cells (IECs) taken from the transwell membrane of a transwell
co-culture model in the presence of the live probiotic L. paracasei or its
supernatant, Salmonella or both. The fold change (Fc) represents the ratio
of the expression in the treated IECs to that of expression in the control
cells.
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